Pharmacological modulators of TRPM4 have been explored for a variety of conditions, including cancer, stroke, multiple sclerosis and heart disease (Bianchi et al., 2018; Dienes et al., 2021; Kovács et al., 2022). Here, TRPM4 is linked to cancer.